Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
2 Months : From Sep 2019 to Nov 2019
By Colin Kellaher
Gilead Sciences Inc. (GILD) Tuesday said it named Andrew Dickinson chief financial officer, effective Nov. 1.
The Foster City, Calif., biopharmaceutical company said Mr. Dickinson succeeds Robin Washington, who earlier this year announced plans to retire.
Mr. Dickinson, who joined Gilead in 2016, currently serves as executive vice president of corporate development and strategy and will retain responsibility for those functions, the company said.
Gilead in April said Ms. Washington would remain in an advisory capacity through the completion of the company's reporting of its 2019 financial results early next year.
Write to Colin Kellaher at firstname.lastname@example.org
(END) Dow Jones Newswires
October 15, 2019 08:56 ET (12:56 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.